https://www.selleckchem.com/pr....oducts/Rapamycin.htm
27; 95% CI, 3.21-183.36; 0.001). Moreover, individuals treated with hypoglycemic agents had significantly lower all-cause mortality than those not treated with hypoglycemic agents (IRR 0.08; 95% CI, 0.01-0.56; 0.001). Our study reinforces the clinical message that NDD is strongly associated with poor outcomes in COVID-19 patients. Furthermore, resolved hyperglycemia in the later phase of the disease and the use of hypoglycemic agents were associated with improved prognosis in patients with NDD. Our study reinforces the clini
Like
Comment
Share
